eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT

Cisplatin is the first-line chemotherapy drug for gastric cancer (GC), but treatment failure often occurs due to development of resistance. The mechanism of cisplatin resistance remains a mystery. Eukaryotic translation initiation factor 5A2 (eIF5A2) is an important tumor-promoting factor and has be...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Transl Res
Main Authors: Sun, Jiancheng, Xu, Zhiyuan, Lv, Hang, Wang, Yiping, Wang, Lijing, Ni, Yixiu, Wang, Xiaofeng, Hu, Can, Chen, Shangqi, Teng, Fei, Chen, Wei, Cheng, Xiangdong
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2018
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325524/
https://ncbi.nlm.nih.gov/pubmed/30662669
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki